Hikal Ltd share price logo

Hikal Ltd Share Price

(HIKAL)

₹401.84.81%

as on 04:01PM, 18 Mar 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Hikal Performance

  • Day's Low

    Day's High

    ₹384.6
    Day's Price Range
    ₹405
  • 52 Week's Low

    52 Week's High

    ₹260.3
    52-Week Price Range
    ₹464.75
1 Month Return+ 11.16 %
3 Month Return-3.46 %
1 Year Return+ 41.98 %
Previous Close₹383.35
Open₹387.20
Volume3.72L
Upper Circuit-
Lower Circuit-
Market Cap₹4,726.73Cr

Hikal Fundamentals

P/E Ratio

63.47

PEG Ratio

275.95

Market Cap

₹4,726.73 Cr

P/B Ratio

2.75

EPS

5.64

Dividend Yield

0.45

Sector

Pharmaceuticals

ROE

5.99

Hikal Analyst Rating

based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts offering long term price targets for Hikal. An average target of ₹435

Source: S&P Global Market Intelligence

Hikal Share analysis

Hikal price forecast by 2 analysts

Upside of13.47%

High

₹450

Target

₹435.00

Low

₹420

Hikal target price ₹435, a slight upside of 13.47% compared to current price of ₹401.8. According to 2 analysts rating.

Source: S&P Global Market Intelligence

Key events for Hikal Ltd

  • Hikal Stock Shows Bullish Momentum - 12 Mar, 2025

    Hikal stock has broken out from a bullish inverted head and shoulder pattern, forming higher tops and bottoms. Indicators and oscillators are bullish on both daily and weekly charts.
  • Bullish Sentiment for Hikal Stock in Pharma Sector - 05 Mar, 2025

    Hikal Ltd shows strong bullish sentiment in the pharma sector, with recommendations to buy above ₹360 and targets set between ₹385-395, indicating positive market momentum.

Insights on Hikal Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 20.79% to 21.61% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, HIKAL stock has moved up by 11.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 61.7% return, outperforming this stock by 19.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 121.9% return, outperforming this stock by 127.7%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 68.85% of holdings in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 6.78% to 6.06% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 453.3 Cr → 451.3 Cr (in ₹), with an average decrease of 0.4% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 18.3 Cr → 17.2 Cr (in ₹), with an average decrease of 6.0% per quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 3.22% to 2.92% in Dec 2024 quarter

Hikal Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹438.50Cr (-)₹512.80Cr (↑16.94%)₹403.80Cr (↓21.26%)₹450.80Cr (↑11.64%)₹438.90Cr (↓2.64%)
Net Income₹16.10Cr (-)₹33.90Cr (↑110.56%)₹5.10Cr (↓84.96%)₹18.30Cr (↑258.82%)₹17.20Cr (↓6.01%)
Net Profit Margin3.67% (-)6.61% (↑80.11%)1.26% (↓80.94%)4.06% (↑222.22%)3.92% (↓3.45%)
Value in ₹ crore
Details2021202220232024
Total Assets₹1,926.12Cr (-)₹2,213.12Cr (↑14.90%)₹2,400.52Cr (↑8.47%)₹2,504.30Cr (↑4.32%)
Total Liabilities₹992.70Cr (-)₹1,145.11Cr (↑15.35%)₹1,267.03Cr (↑10.65%)₹1,316.71Cr (↑3.92%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹284.93Cr (-)₹229.02Cr (↓19.62%)₹293.73Cr (↑28.26%)₹315.29Cr (↑7.34%)₹186.62Cr (↓40.81%)

Hikal Index Inclusions

BSE Healthcare

₹40,476.75

1.87 (742.84%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

BSE Small-Cap

₹45,031.45

2.73 (1197.18%)

Hikal Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
68.85%
0.00
Foreign Institutions
6.06%
-10.66
Mutual Funds
2.92%
-9.10
Retail Investors
21.61%
3.93
Others
0.56%
55.28

Hikal Key Indicators

Details20202021202220232024
Return On Equity %12.0615.2216.047.125.99
Details20202021202220232024
Return On Assets %4.746.917.253.272.78
Details20202021202220232024
Book Value Per Share (₹)66.2275.786.6291.9396.32
Details20202021202220232024
Earning Per Share (₹)6.8510.813.026.365.64

Hikal Valuation

Hikal in the last 5 years

  • Overview

  • Trends

Lowest (8.33x)

March 24, 2020

Industry (50.70x)

March 17, 2025

Today (63.47x)

March 17, 2025

Highest (81.58x)

January 3, 2023

LowHigh

Hikal Earnings and Dividends

  • Hikal Ltd Earnings Results

    Hikal Ltd’s net profit jumped 6.83% since last year same period to ₹17.20Cr in the Q3 2024-2025. On a quarterly growth basis, Hikal Ltd has generated -6.01% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Hikal Ltd Dividends February,2025

    In the quarter ending December 2024, Hikal Ltd has declared dividend of ₹0.60 - translating a dividend yield of 0.45%.

    Read More about Dividends

Hikal Technicals Summary

Bearish

Neutral

Bullish

Bullish

Hikal Ltd is currently in a Bullish trading position according to technical analysis indicators.

Hikal Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹4,726.73 Cr81.89%0.72₹69 Cr₹1,784 Cr
BUY₹28,896.94 Cr157.81%0.52₹300 Cr₹1,051 Cr
BUY₹13,639.27 Cr49.71%0.57₹72 Cr₹6,702 Cr
NA₹3,805.02 Cr3.66%0.79-₹388 Cr₹75 Cr
BUY₹12,694.97 Cr35.54%0.68₹218 Cr₹1,296 Cr

About Hikal

Hikal Limited is an Indian-based company, incorporated in 1988, with global recognition in the pharmaceutical, crop protection, animal health, biocides and specialty chemicals industries. It has 5 manufacturing facilities in 3 states, producing various chemical intermediates, active pharma ingredients, APIs and contract research activities. With their multiple partnerships and technological expansion projects, they have achieved milestones such as receiving the 5 Star Safety Award from the UK British Safety Council and their promotion to a trading house status. They have acquired an agrochemical manufacturing site from Novartis India Limited, which was followed by an investment in a JV with a Sinochem Corporation China subsidiary. Furthermore, they provide human and animal health products, amongst others. Recent developments such as the long-term contracts with life science companies, the sale of the RD unit and the bonus share issuance to shareholders indicate the company's success.

Revenue: ₹438.90Cr as on December 2024 (Q4 24)
Net Profit: ₹17.20Cr as on December 2024 (Q4 24)
Listing date: 14 Feb, 2001
Chairperson Name: Jai Hiremath
OrganisationHikal
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Hikal Ltd

What is Hikal Ltd price today?

Hikal Ltd share price today stands at ₹401.8, Open: ₹387.2, Previous Close: ₹383.35, High: ₹405, Low: ₹384.6, 52 Week High: ₹464.75, 52 Week Low: ₹260.3.

How to Buy Hikal Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Hikal Ltd shares

What are today's traded volumes of Hikal Ltd?

Today's traded volume of Hikal Ltd(HIKAL) is 3.72L.

What is today's market capitalisation of Hikal Ltd?

Today's market capitalisation of Hikal Ltd(HIKAL) is ₹4726.73Cr.

What is the 52 Week High and Low Range of Hikal Ltd?

Hikal Ltd (HIKAL)
Price
52 Week High
₹464.75
52 Week Low
₹260.3

How much percentage Hikal Ltd is down from its 52 Week High?

Hikal Ltd (HIKAL) share price is ₹401.8. It is down -13.54% from its 52 Week High price of ₹464.75

How much percentage Hikal Ltd is up from its 52 Week low?

Hikal Ltd (HIKAL) share price is ₹401.8. It is up 54.36% from its 52 Week Low price of ₹260.3